Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Why Up to 75% of People on Weight-Loss Drugs Stop Taking Them, Cardiologist Says
For those who have struggled with the scale, the treatments can help achieve results and improve overall health (and do so quickly). But with any seemingly foolproof solution, there is always some catch,
Weight-loss drugs replacing some surgeries, but doctors say they're 'not a miracle drug'
Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, rates of bariatric surgeries dropped by 25%, while prescriptions for weight-loss drugs more than doubled.
Weight loss drugs Ozempic and Wegovy may also curb alcohol addiction, study says
A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at curbing alcohol abuse.
Take a look at a dieter’s weight loss journey using Ozempic
People who take popular weight loss drugs like Ozempic can have serious side effects and new research says stopping them can also cause problems. Now that millions of people have successfully lost weight using them,
Mimic Ozempic's Weight Loss Effects Naturally With a Keto-Based Diet
Everyone is raving about the slimming power of semaglutide medications like Ozempic and Wegovy, which experts say is as effective as weight loss surgery. While it's not for everyone, it can be a lifesaving option for some.
Do Weight Loss Drugs Like Ozempic Affect Your Breast Health?
Medically reviewed by Danielle Weiss, MD After losing extra pounds on Ozempic (semaglutide), some are finding themselves dealing with an unexpected issue, what's become known as "Ozempic breasts." This possible side effect of glucagon-like peptide 1 (GLP-1) agonist medication users like Ozempic,
The Brighterside of News on MSN
6h
Revolutionary obesity and diabetes treatment burns energy and reduces appetite without side effects
Long-acting pharmacotherapies targeting incretin hormones like glucagon-like peptide-1 (GLP-1) and glucose-dependent ...
Futurism on MSN
8h
Mounjaro Appears to Be Extremely Effective at Preventing Diabetes
A new study has found that Mounjaro may not only be good at treating diabetes, but could actually help prevent the disease.
pulmonologyadvisor
1d
GLP-1 Drug Shortages: How Do They Affect Patients With Diabetes?
GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...
Medscape
4h
Tirzepatide Reduces Heart Failure Events in HFpEF With Obesity
SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart ...
2d
GLP-1 RA use tied to lower rate of venous thromboembolism in diabetes
For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...
The American Journal of Managed Care
8h
For Obesity and HFpEF, Tirzepatide Cuts Risk of CV Death or Worsening HF by 38%
Payers and employers have tightened access to the glucagon-like peptide-1 receptor agonist class once these therapies became ...
3d
Ozempic, Wegovy Linked To Lower Hospitalizations In Alcohol Addicts, Research Shows
GLP-1 drugs have been linked to numerous potential health benefits like treatment of existing conditions including heart ...
2d
Comparing Oral vs. Injectable Semaglutide: Is One More Effective Than the Other?
It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...
Yahoo
3d
The Woman’s World Expert-Reviewed Glossary of GLP-1, Semaglutide and Telehealth
Garner, MD, Medical Director at SimpleFixRx to review it all for accuracy. Dr, Garner said, "
Glucagon-like
peptide-1
(GLP ...
HealthDay on MSN
3d
AHA: GLP-1 RA, SGLT-2i Use Can Lower Risk for MI, Recurrent Stroke in Stroke Survivors
For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback